Showing results (131-140 of 169) with videos related to
Sort By:
Pageof 17
Pediatric Surgery International|July 28, 2016
Risk factors and prevention for surgical intestinal disorders in extremely low birth weight infantsMasaya Yamoto, Yusuke Nakazawa, Koji Fukumoto, et al.Cancer Medicine|August 20, 2021
Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancerHisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, et al.Thoracic Cancer|October 12, 2020
Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumabHiroyuki Minemura, Hiroshi Moriya, Hisao Imai, et al.Journal of Cancer|February 6, 2023
C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditionsShinjiro Nagao, Hideya Onishi, Makoto Kawamoto, et al.Scientific Reports|May 10, 2020
Functional and anatomical changes in diabetic macular edema after hemodialysis initiation: One-year follow-up multicenter studyYoshihiro Takamura, Takehiro Matsumura, Kishiko Ohkoshi, et al.The Plant Journal : for Cell and Molecular Biology|November 27, 2013
Enhancement of oxidative and drought tolerance in Arabidopsis by overaccumulation of antioxidant flavonoidsRyo Nakabayashi, Keiko Yonekura-Sakakibara, Kaoru Urano, et al.Oncology|July 8, 2021
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab MonotherapyHisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, et al.Scientific Reports|January 4, 2025
Cystoid macular oedema after flanged intraocular lens scleral fixation using the Yamane technique: a multicentre cohort studyHiroto Ishikawa, Kazutaka Uchida, Hiroto Terasaki, et al.Cancer Science|July 13, 2023
Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axisMasataka Hayashi, Naoki Ikenaga, Kohei Nakata, et al.Cancer Medicine|June 14, 2022
Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancerAyako Shiono, Hisao Imai, Satoshi Wasamoto, et al.Pageof 17